Medical Properties Trust Key Executives
This section highlights Medical Properties Trust's key executives, including their titles and compensation details.
Find Contacts at Medical Properties Trust
(Showing 0 of )
Medical Properties Trust Earnings
This section highlights Medical Properties Trust's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-02-27 | $0.16 | $0.18 |
| Read Transcript | Q3 | 2024 | 2024-11-07 | $0.20 | $0.16 |
| Read Transcript | Q2 | 2024 | 2024-08-08 | $0.20 | $0.23 |
| Read Transcript | Q1 | 2024 | 2024-05-09 | $0.25 | $0.24 |
| Read Transcript | Q4 | 2023 | 2024-02-21 | $0.27 | $0.36 |
| Read Transcript | Q3 | 2023 | 2023-10-26 | $0.35 | $0.38 |
| Read Transcript | Q2 | 2023 | 2023-08-08 | $0.38 | $0.48 |
| Read Transcript | Q1 | 2023 | 2023-04-27 | $0.37 | $0.37 |
Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023. Since the end of the third quarter, the Company has sold four facilities and now owns approximately 43,000 licensed beds in nine countries across three continents. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
$6.03
Stock Price
$3.62B
Market Cap
118
Employees
Birmingham, AL
Location
Financial Statements
Access annual & quarterly financial statements for Medical Properties Trust, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $995.55M | $871.80M | $1.54B | $1.54B | $1.25B |
| Cost of Revenue | $27.25M | $41.57M | $45.70M | $39.10M | $24.89M |
| Gross Profit | $968.29M | $830.23M | $1.50B | $1.51B | $1.22B |
| Gross Profit Ratio | 97.26% | 95.20% | 97.04% | 97.50% | 98.01% |
| Research and Development Expenses | $- | $- | $1 | $0 | $0 |
| General and Administrative Expenses | $133.79M | $145.59M | $160.49M | $145.64M | $131.66M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $133.79M | $145.59M | $160.49M | $145.64M | $131.66M |
| Other Expenses | $- | $- | $332.98M | $321.25M | $264.25M |
| Operating Expenses | $133.79M | $145.59M | $493.47M | $466.89M | $395.91M |
| Cost and Expenses | $133.79M | $790.51M | $539.17M | $505.99M | $420.80M |
| Interest Income | $- | $- | $- | $- | $- |
| Interest Expense | $- | $- | $- | $- | $- |
| Depreciation and Amortization | $453.75M | $603.36M | $539.17M | $505.99M | $420.80M |
| EBITDA | $840.60M | $684.64M | $1.34B | $1.36B | $1.09B |
| EBITDA Ratio | 84.44% | 78.53% | 42.66% | 45.63% | 44.23% |
| Operating Income | $861.76M | $81.28M | $1.00B | $1.04B | $828.44M |
| Operating Income Ratio | 86.56% | 9.32% | 65.05% | 67.24% | 66.32% |
| Total Other Income Expenses Net | $-3.23B | $-768.05M | $-43.96M | $-307.80M | $-365.11M |
| Income Before Tax | $-2.36B | $-686.77M | $959.72M | $730.89M | $463.33M |
| Income Before Tax Ratio | -237.48% | -78.78% | 62.20% | 47.32% | 37.09% |
| Income Tax Expense | $44.10M | $-130.68M | $55.90M | $73.95M | $31.06M |
| Net Income | $-2.32B | $-556.48M | $902.60M | $656.02M | $431.45M |
| Net Income Ratio | -233.05% | -63.83% | 58.50% | 42.47% | 34.54% |
| EPS | $-3.86 | $-0.93 | $1.50 | $1.11 | $0.81 |
| EPS Diluted | $-3.86 | $-0.93 | $1.50 | $1.11 | $0.81 |
| Weighted Average Shares Outstanding | 600.25M | 598.52M | 598.63M | 588.82M | 529.24M |
| Weighted Average Shares Outstanding Diluted | 600.25M | 598.52M | 598.84M | 590.14M | 530.46M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $231.84M | $225.83M | $266.56M | $271.32M | $-122.38M | $306.58M | $337.39M | $350.21M | $380.49M | $352.34M | $400.23M | $409.80M | $409.33M | $390.78M | $381.79M | $362.76M | $333.81M | $329.46M | $291.84M | $294.13M |
| Cost of Revenue | $- | $516.13M | $109.90M | $80.40M | $3.30M | $6.48M | $24.68M | $7.11M | $7.70M | $8.27M | $21.14M | $8.60M | $7.83M | $7.13M | $18.68M | $5.45M | $5.71M | $5.90M | $9.98M | $5.57M |
| Gross Profit | $231.84M | $-290.30M | $156.66M | $190.91M | $-125.68M | $300.09M | $312.72M | $343.10M | $372.79M | $344.07M | $379.09M | $401.20M | $401.50M | $383.65M | $363.11M | $357.31M | $328.09M | $323.56M | $281.86M | $288.56M |
| Gross Profit Ratio | 100.00% | -128.50% | 58.80% | 70.40% | 102.70% | 97.90% | 92.70% | 98.00% | 98.00% | 97.70% | 94.70% | 97.90% | 98.10% | 98.20% | 95.10% | 98.50% | 98.29% | 98.21% | 96.58% | 98.11% |
| Research and Development Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| General and Administrative Expenses | $28.49M | $36.62M | $35.33M | $33.35M | $30.15M | $38.11M | $35.60M | $41.72M | $42.89M | $37.32M | $38.86M | $41.42M | $38.33M | $36.69M | $34.55M | $36.07M | $34.54M | $31.72M | $32.02M | $33.38M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $28.49M | $36.62M | $35.33M | $33.35M | $30.15M | $38.11M | $35.60M | $41.72M | $42.89M | $37.32M | $38.86M | $41.42M | $38.33M | $36.69M | $34.55M | $36.07M | $34.54M | $31.72M | $32.02M | $33.38M |
| Other Expenses | $- | $- | $-167.69M | $-33.35M | $77.30M | $77.80M | $364.40M | $83.86M | $81.45M | $81.87M | $84.33M | $85.32M | $84.20M | $85.04M | $76.37M | $75.64M | $72.20M | $69.67M | $61.46M | $60.92M |
| Operating Expenses | $28.49M | $36.62M | $137.57M | $33.35M | $107.44M | $115.91M | $400.01M | $125.58M | $124.35M | $119.19M | $123.19M | $126.74M | $122.53M | $121.73M | $110.91M | $111.72M | $106.74M | $101.38M | $93.48M | $94.31M |
| Cost and Expenses | $28.49M | $552.75M | $145.39M | $113.75M | $110.74M | $122.39M | $424.68M | $132.69M | $132.05M | $127.46M | $144.33M | $135.34M | $130.36M | $128.86M | $129.60M | $117.17M | $112.45M | $107.28M | $103.47M | $99.88M |
| Interest Income | $- | $-713.00K | $- | $- | $- | $862.00K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Interest Expense | $- | $106.24M | $- | $108.69M | $- | $106.71M | $- | $97.65M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $82.26M | $80.38M | $- |
| Depreciation and Amortization | $66.20M | $204.88M | $102.24M | $75.59M | $77.30M | $77.80M | $364.40M | $83.86M | $81.45M | $81.87M | $84.33M | $85.32M | $84.20M | $85.04M | $76.37M | $75.64M | $72.20M | $69.67M | $61.46M | $60.92M |
| EBITDA | $2.10B | $-587.02M | $223.41M | $17.15M | $-140.67M | $261.98M | $277.12M | $221.81M | $-318.70M | $306.75M | $340.23M | $359.78M | $363.17M | $346.96M | $328.56M | $321.24M | $293.55M | $291.84M | $249.84M | $255.18M |
| EBITDA Ratio | 904.97% | -259.94% | 83.81% | 85.93% | 255.80% | 33.77% | -134.93% | 37.10% | 42.99% | 40.59% | 42.87% | 46.16% | 47.58% | 45.26% | 46.05% | 46.85% | 44.68% | 46.29% | 43.49% | 45.33% |
| Operating Income | $203.35M | $-326.93M | $121.17M | $157.56M | $-233.13M | $184.18M | $-87.29M | $217.52M | $248.44M | $224.88M | $255.90M | $274.46M | $278.98M | $261.92M | $252.19M | $245.60M | $221.36M | $222.18M | $188.38M | $194.25M |
| Operating Income Ratio | 87.71% | -144.77% | 45.46% | 58.07% | 190.49% | 60.08% | -25.87% | 62.11% | 65.30% | 63.83% | 63.94% | 66.97% | 68.15% | 67.02% | 66.06% | 67.70% | 66.31% | 67.44% | 64.55% | 66.04% |
| Total Other Income Expenses Net | $-606.11M | $-464.97M | $-288.93M | $-1.02B | $-426.48M | $-57.23M | $-103.41M | $-180.94M | $-373.37M | $15.72M | $-55.18M | $368.86M | $-67.32M | $-79.92M | $-87.19M | $-73.36M | $-105.02M | $-74.84M | $-73.89M | $-109.09M |
| Income Before Tax | $-402.76M | $-791.90M | $-305.10M | $-724.43M | $-659.60M | $126.95M | $-190.69M | $36.57M | $-124.93M | $240.60M | $200.72M | $643.33M | $211.65M | $182.00M | $165.00M | $172.24M | $116.34M | $147.34M | $114.48M | $85.17M |
| Income Before Tax Ratio | -173.72% | -350.67% | -114.46% | -267.01% | 538.97% | 41.41% | -56.52% | 10.44% | -32.83% | 68.29% | 50.15% | 156.99% | 51.71% | 46.57% | 43.22% | 47.48% | 34.85% | 44.72% | 39.23% | 28.96% |
| Income Tax Expense | $-9.56M | $9.03M | $14.56M | $10.95M | $3.98M | $10.06M | $-148.26M | $3.54M | $15.29M | $18.58M | $10.66M | $11.38M | $4.81M | $10.60M | $50.18M | $8.36M | $6.23M | $15.98M | $4.83M | $4.01M |
| Net Income | $-393.20M | $-801.16M | $-321.29M | $-735.62M | $-663.94M | $116.71M | $-42.04M | $32.79M | $-140.47M | $221.79M | $189.60M | $631.68M | $206.54M | $171.14M | $114.56M | $163.78M | $109.88M | $131.11M | $109.47M | $80.99M |
| Net Income Ratio | -169.60% | -354.77% | -120.53% | -271.13% | 542.51% | 38.07% | -12.46% | 9.36% | -36.92% | 62.95% | 47.37% | 154.14% | 50.46% | 43.79% | 30.01% | 45.15% | 32.92% | 39.79% | 37.51% | 27.54% |
| EPS | $-0.65 | $-1.34 | $-0.54 | $-1.23 | $-1.11 | $0.19 | $-0.07 | $0.05 | $-0.23 | $0.37 | $0.32 | $1.05 | $0.34 | $0.29 | $0.19 | $0.28 | $0.20 | $0.25 | $0.21 | $0.15 |
| EPS Diluted | $-0.65 | $-1.34 | $-0.54 | $-1.23 | $-1.11 | $0.19 | $-0.07 | $0.05 | $-0.23 | $0.37 | $0.32 | $1.05 | $0.34 | $0.29 | $0.19 | $0.28 | $0.20 | $0.25 | $0.21 | $0.15 |
| Weighted Average Shares Outstanding | 600.40M | 600.23M | 600.06M | 600.30M | 598.98M | 598.44M | 598.34M | 598.30M | 598.05M | 598.98M | 598.83M | 598.68M | 596.39M | 595.12M | 587.51M | 576.24M | 537.00M | 531.10M | 527.78M | 521.08M |
| Weighted Average Shares Outstanding Diluted | 600.40M | 600.23M | 600.06M | 600.30M | 598.98M | 598.55M | 598.34M | 598.31M | 598.05M | 599.34M | 599.03M | 598.93M | 596.66M | 597.32M | 589.05M | 577.54M | 538.35M | 532.44M | 528.88M | 522.18M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $332.33M | $250.02M | $235.67M | $459.23M | $549.88M |
| Short Term Investments | $- | $- | $1.69B | $- | $- |
| Cash and Short Term Investments | $332.33M | $250.02M | $235.67M | $459.23M | $549.88M |
| Net Receivables | $737.11M | $681.05M | $1.18B | $2.11B | $1.40B |
| Inventory | $- | $- | $-304.52M | $1.24B | $1 |
| Other Current Assets | $- | $442.08M | $- | $- | $- |
| Total Current Assets | $1.07B | $1.40B | $1.42B | $2.57B | $1.94B |
| Property Plant Equipment Net | $- | $299.93M | $13.86B | $201.21M | $8.23M |
| Goodwill | $- | $- | $12.47B | $- | $- |
| Intangible Assets | $804.08M | $1.03B | $1.39B | $1.42B | $1.30B |
| Goodwill and Intangible Assets | $804.08M | $1.03B | $13.86B | $1.42B | $1.30B |
| Long Term Investments | $1.60B | $3.25B | $2.94B | $1.18B | $1.12B |
| Tax Assets | $- | $- | $19.66B | $-201.21M | $-8.23M |
| Other Non-Current Assets | $10.58B | $11.07B | $-32.09B | $15.35B | $12.46B |
| Total Non-Current Assets | $12.98B | $15.66B | $18.24B | $17.95B | $14.88B |
| Other Assets | $244.27M | $1.25B | $- | $- | $- |
| Total Assets | $14.29B | $18.30B | $19.66B | $20.52B | $16.83B |
| Account Payables | $- | $412.18M | $621.32M | $603.59M | $387.45M |
| Short Term Debt | $129.04M | $472.49M | $483.32M | $4.20M | $51.30M |
| Tax Payables | $- | $- | $- | $- | $- |
| Deferred Revenue | $29.45M | $37.96M | $27.73M | $25.56M | $36.18M |
| Other Current Liabilities | $- | $1.04B | $-483.32M | $-25.56M | $-293.98M |
| Total Current Liabilities | $158.49M | $1.96B | $649.05M | $633.36M | $474.93M |
| Long Term Debt | $129.04M | $9.77B | $9.93B | $11.44B | $8.84B |
| Deferred Revenue Non-Current | $- | $- | $27.73M | $25.56M | $36.18M |
| Deferred Tax Liabilities Non-Current | $- | $- | $-691.65M | $-704.21M | $93.62M |
| Other Non-Current Liabilities | $9.17B | $-1.06B | $483.32M | $25.56M | $165.41M |
| Total Non-Current Liabilities | $9.30B | $8.71B | $10.41B | $11.44B | $9.01B |
| Other Liabilities | $390.00K | $- | $- | $- | $- |
| Total Liabilities | $9.46B | $10.67B | $11.06B | $12.07B | $9.49B |
| Preferred Stock | $- | $- | $116.28M | $- | $- |
| Common Stock | $- | $599.00K | $597.00K | $597.00K | $541.00K |
| Retained Earnings | $- | $-971.81M | $116.28M | $-87.69M | $-71.41M |
| Accumulated Other Comprehensive Income Loss | $-94.27M | $42.50M | $-59.18M | $-36.73M | $-51.32M |
| Other Total Stockholders Equity | $4.93B | $8.56B | $8.54B | $8.56B | $7.46B |
| Total Stockholders Equity | $4.83B | $7.63B | $8.59B | $8.44B | $7.34B |
| Total Equity | $4.84B | $7.63B | $8.59B | $8.45B | $7.34B |
| Total Liabilities and Stockholders Equity | $14.29B | $18.30B | $19.66B | $20.52B | $16.83B |
| Minority Interest | $1.05M | $2.27M | $1.57M | $5.48M | $5.33M |
| Total Liabilities and Total Equity | $14.29B | $18.30B | $19.66B | $20.52B | $16.83B |
| Total Investments | $1.60B | $3.25B | $4.63B | $1.18B | $1.12B |
| Total Debt | $129.04M | $10.22B | $11.34B | $11.44B | $9.01B |
| Net Debt | $-203.29M | $9.97B | $11.11B | $10.98B | $8.46B |
Balance Sheet Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $332.33M | $275.62M | $606.55M | $224.34M | $250.02M | $340.06M | $324.05M | $302.32M | $235.67M | $299.17M | $257.27M | $248.85M | $459.23M | $349.65M | $721.32M | $746.75M | $549.88M | $183.79M | $374.96M | $500.21M |
| Short Term Investments | $- | $- | $- | $- | $43.00M | $- | $- | $1.58B | $1.69B | $- | $2.08B | $- | $2.05B | $- | $- | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $332.33M | $275.62M | $606.55M | $224.34M | $250.02M | $340.06M | $324.05M | $302.32M | $235.67M | $299.17M | $257.27M | $248.85M | $2.51B | $349.65M | $721.32M | $746.75M | $549.88M | $183.79M | $374.96M | $500.21M |
| Net Receivables | $737.11M | $720.88M | $703.74M | $1.14B | $681.05M | $1.25B | $1.16B | $1.26B | $1.18B | $1.03B | $1.01B | $793.32M | $2.11B | $2.23B | $2.19B | $2.11B | $1.40B | $1.39B | $1.21B | $940.88M |
| Inventory | $- | $- | $- | $1 | $-43.00M | $1 | $1 | $1.28B | $-304.52M | $1.13B | $2.08B | $1 | $- | $-112.93M | $1.40B | $1.34B | $-87.95M | $-916.75M | $-797.97M | $1 |
| Other Current Assets | $- | $- | $510.56M | $- | $615.79M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Current Assets | $1.07B | $1.15B | $1.82B | $1.36B | $1.40B | $1.59B | $1.48B | $1.56B | $1.42B | $1.33B | $1.27B | $1.04B | $2.57B | $2.58B | $2.91B | $2.86B | $1.94B | $1.57B | $1.59B | $1.44B |
| Property Plant Equipment Net | $- | $- | $10.53B | $11.40B | $299.93M | $11.73B | $11.88B | $13.09B | $13.86B | $11.99B | $13.70B | $12.97B | $201.21M | $196.90M | $12.42B | $11.20B | $10.06B | $10.58B | $9.31B | $9.31B |
| Goodwill | $- | $- | $- | $- | $- | $- | $- | $- | $12.47B | $- | $- | $- | $12.64B | $- | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $11.26B | $11.65B | $11.95B | $12.82B | $13.24B | $13.04B | $13.13B | $13.09B | $1.39B | $13.08B | $13.70B | $14.03B | $1.42B | $13.24B | $13.39B | $12.11B | $1.30B | $11.34B | $9.99B | $9.93B |
| Goodwill and Intangible Assets | $11.26B | $11.65B | $11.95B | $12.82B | $13.24B | $13.04B | $13.13B | $13.09B | $13.86B | $13.08B | $13.70B | $14.03B | $14.06B | $13.24B | $13.39B | $12.11B | $1.30B | $11.34B | $9.99B | $9.93B |
| Long Term Investments | $1.60B | $1.75B | $1.78B | $2.25B | $3.30B | $3.31B | $3.30B | $2.82B | $2.94B | $2.85B | $2.90B | $2.99B | $1.18B | $1.17B | $1.18B | $1.08B | $1.12B | $864.94M | $841.10M | $834.43M |
| Tax Assets | $- | $- | $-11.55B | $-12.51B | $-40.74M | $-11.73B | $-11.88B | $- | $- | $-11.99B | $- | $-12.97B | $-201.21M | $-196.90M | $-12.42B | $-11.20B | $-10.06B | $-10.58B | $-9.31B | $-9.31B |
| Other Non-Current Assets | $125.07M | $678.81M | $1.67B | $1.98B | $109.04M | $1.07B | $1.29B | $-10.91B | $-12.43B | $1.78B | $-11.82B | $-11.22B | $2.50B | $2.52B | $-10.81B | $-8.50B | $2.40B | $-8.38B | $-6.28B | $-6.28B |
| Total Non-Current Assets | $12.98B | $14.08B | $14.38B | $15.94B | $16.91B | $17.42B | $17.72B | $18.09B | $18.24B | $17.72B | $18.48B | $18.78B | $17.95B | $17.13B | $16.18B | $15.89B | $14.88B | $14.40B | $13.86B | $13.80B |
| Other Assets | $244.27M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $14.29B | $15.24B | $16.19B | $17.30B | $18.30B | $19.00B | $19.20B | $19.65B | $19.66B | $19.04B | $19.74B | $19.82B | $20.52B | $19.71B | $19.09B | $18.75B | $16.83B | $15.98B | $15.45B | $15.24B |
| Account Payables | $- | $- | $446.89M | $302.53M | $412.18M | $375.89M | $444.93M | $595.27M | $621.32M | $569.02M | $562.25M | $595.03M | $603.59M | $595.00M | $- | $- | $387.45M | $431.18M | $- | $- |
| Short Term Debt | $129.04M | $136.63M | $- | $438.84M | $472.49M | $439.40M | $508.12M | $493.48M | $483.32M | $146.44M | $154.97M | $166.63M | $158.00M | $157.49M | $148.08M | $158.80M | $51.30M | $- | $122.81M | $119.15M |
| Tax Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $29.45M | $24.33M | $25.70M | $32.08M | $37.96M | $32.28M | $49.77M | $29.39M | $27.73M | $18.57M | $21.21M | $18.83M | $25.56M | $19.74M | $21.19M | $21.53M | $36.18M | $17.30M | $18.64M | $24.00M |
| Other Current Liabilities | $- | $257.37M | $-25.70M | $1.18B | $1.04B | $-32.28M | $-49.77M | $-29.39M | $-483.32M | $-569.02M | $-562.25M | $-595.03M | $-603.59M | $-177.23M | $504.62M | $265.26M | $-293.98M | $207.70M | $- | $- |
| Total Current Liabilities | $158.49M | $418.34M | $1.16B | $1.95B | $1.96B | $408.17M | $494.69M | $624.66M | $649.05M | $587.59M | $583.47M | $613.86M | $633.36M | $614.74M | $673.88M | $467.13M | $474.93M | $656.18M | $462.09M | $452.14M |
| Long Term Debt | $129.04M | $9.35B | $9.37B | $9.66B | $9.71B | $9.87B | $9.89B | $10.09B | $9.93B | $9.48B | $10.14B | $9.59B | $9.84B | $9.69B | $10.05B | $9.82B | $8.84B | $8.19B | $7.92B | $7.80B |
| Deferred Revenue Non-Current | $- | $- | $25.70M | $32.08M | $37.96M | $32.28M | $49.77M | $29.39M | $27.73M | $18.57M | $21.21M | $18.83M | $25.56M | $19.74M | $21.19M | $21.53M | $36.18M | $17.30M | $18.64M | $24.00M |
| Deferred Tax Liabilities Non-Current | $- | $- | $-446.89M | $-195.34M | $-1.41B | $-562.39M | $-652.10M | $-768.75M | $-691.65M | $-734.02M | $-738.44M | $-780.49M | $-704.21M | $- | $- | $-10.47B | $-180.95M | $- | $-141.45M | $-143.15M |
| Other Non-Current Liabilities | $9.17B | $-397.39M | $185.71M | $195.34M | $-1.00B | $439.40M | $49.77M | $493.48M | $483.32M | $569.02M | $562.25M | $716.88M | $1.63B | $1.05B | $-86.10M | $137.27M | $423.21M | $413.88M | $- | $- |
| Total Non-Current Liabilities | $9.30B | $8.95B | $8.84B | $8.65B | $8.71B | $10.31B | $10.39B | $10.58B | $10.41B | $9.62B | $10.29B | $10.28B | $11.44B | $10.74B | $10.20B | $10.16B | $9.01B | $8.11B | $7.92B | $7.80B |
| Other Liabilities | $- | $421.72M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $9.46B | $9.80B | $10.00B | $10.60B | $10.67B | $10.72B | $10.89B | $11.21B | $11.06B | $10.21B | $10.88B | $10.90B | $12.07B | $11.35B | $10.87B | $10.63B | $9.49B | $8.77B | $8.38B | $8.26B |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $13.00K | $280.00K |
| Common Stock | $600.00K | $600.00K | $600.00K | $600.00K | $599.00K | $598.00K | $598.00K | $598.00K | $597.00K | $599.00K | $599.00K | $599.00K | $597.00K | $596.00K | $589.00K | $583.00K | $541.00K | $536.00K | $529.00K | $522.00K |
| Retained Earnings | $-3.66B | $-3.20B | $-2.35B | $-1.85B | $-971.81M | $-215.06M | $-241.30M | $-25.41M | $116.28M | $433.34M | $385.55M | $369.97M | $-87.69M | $-117.73M | $-121.64M | $-71.07M | $-71.41M | $-33.62M | $-19.77M | $14.03M |
| Accumulated Other Comprehensive Income Loss | $-94.27M | $57.11M | $-33.91M | $-18.84M | $42.50M | $-59.78M | $6.68M | $-74.92M | $-59.18M | $-139.30M | $-83.43M | $-5.01M | $-36.73M | $-69.84M | $-53.50M | $-66.72M | $-51.32M | $-96.00M | $-113.01M | $-111.28M |
| Other Total Stockholders Equity | $8.58B | $8.58B | $8.57B | $8.57B | $8.56B | $8.56B | $8.55B | $8.54B | $8.54B | $8.54B | $8.56B | $8.55B | $8.56B | $8.54B | $8.39B | $8.25B | $7.46B | $7.34B | $7.20B | $7.08B |
| Total Stockholders Equity | $4.83B | $5.44B | $6.19B | $6.70B | $7.63B | $8.28B | $8.31B | $8.44B | $8.59B | $8.83B | $8.86B | $8.91B | $8.44B | $8.35B | $8.21B | $8.11B | $7.34B | $7.21B | $7.07B | $6.98B |
| Total Equity | $4.83B | $5.44B | $6.19B | $6.70B | $7.63B | $8.29B | $8.31B | $8.44B | $8.59B | $8.83B | $8.87B | $8.92B | $8.45B | $8.36B | $8.22B | $8.12B | $7.34B | $7.21B | $7.07B | $6.98B |
| Total Liabilities and Stockholders Equity | $14.29B | $15.24B | $16.19B | $17.30B | $18.30B | $19.00B | $19.20B | $19.65B | $19.66B | $19.04B | $19.74B | $19.82B | $20.52B | $19.71B | $19.09B | $18.75B | $16.83B | $15.98B | $15.45B | $15.24B |
| Minority Interest | $1.05M | $2.54M | $2.90M | $2.27M | $2.27M | $887.00K | $902.00K | $1.57M | $1.57M | $1.47M | $6.04M | $5.91M | $5.48M | $5.40M | $5.34M | $5.23M | $5.33M | $5.24M | $106.00K | $107.00K |
| Total Liabilities and Total Equity | $14.29B | $15.24B | $16.19B | $17.30B | $18.30B | $19.00B | $19.20B | $19.65B | $19.66B | $19.04B | $19.74B | $19.82B | $20.52B | $19.71B | $19.09B | $18.75B | $16.83B | $15.98B | $15.45B | $15.24B |
| Total Investments | $1.60B | $1.75B | $1.78B | $2.25B | $3.30B | $3.31B | $3.30B | $1.58B | $4.63B | $2.85B | $4.98B | $2.99B | $3.23B | $1.17B | $1.18B | $1.08B | $1.12B | $864.94M | $841.10M | $834.43M |
| Total Debt | $129.04M | $9.35B | $9.37B | $10.10B | $10.17B | $10.31B | $10.39B | $10.58B | $11.34B | $10.26B | $11.21B | $10.82B | $11.60B | $10.74B | $10.20B | $10.16B | $9.01B | $8.19B | $7.92B | $7.80B |
| Net Debt | $-203.29M | $9.08B | $8.76B | $9.87B | $9.92B | $9.97B | $10.07B | $10.28B | $11.11B | $9.96B | $10.96B | $10.57B | $11.14B | $10.39B | $9.47B | $9.41B | $8.46B | $8.01B | $7.54B | $7.30B |
Annual Cash Flow
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $-2.41B | $-556.09M | $903.82M | $656.94M | $432.27M |
| Depreciation and Amortization | $453.75M | $616.13M | $345.58M | $333.78M | $275.95M |
| Deferred Income Tax | $- | $-167.33M | $10.70M | $42.75M | $21.84M |
| Stock Based Compensation | $32.98M | $33.25M | $49.42M | $52.11M | $47.15M |
| Change in Working Capital | $-15.60M | $-125.01M | $29.59M | $13.12M | $17.22M |
| Accounts Receivables | $2.78M | $- | $-116.42M | $-23.87M | $-2.44M |
| Inventory | $- | $- | $116.42M | $23.87M | $2.44M |
| Accounts Payables | $- | $-4.60M | $33.58M | $54.06M | $-18.42M |
| Other Working Capital | $-18.38M | $-120.41M | $-3.99M | $-40.94M | $35.65M |
| Other Non Cash Items | $2.18B | $704.84M | $-600.09M | $-287.04M | $-176.80M |
| Net Cash Provided by Operating Activities | $245.48M | $505.79M | $739.01M | $811.66M | $617.64M |
| Investments in Property Plant and Equipment | $- | $- | $-1.54B | $-65.55M | $-4.29B |
| Acquisitions Net | $- | $-222.76M | $-1.32B | $-5.28B | $-4.18B |
| Purchases of Investments | $- | $-294.17M | $-207.39M | $-289.24M | $-36.18M |
| Sales Maturities of Investments | $11.66M | $12.43M | $14.29M | $65.55M | $1.47B |
| Other Investing Activities | $1.31B | $1.02B | $3.45B | $1.72B | $4.09B |
| Net Cash Used for Investing Activities | $1.32B | $517.56M | $396.06M | $-3.86B | $-2.95B |
| Debt Repayment | $102.38M | $-420.25M | $-537.49M | $2.58B | $1.58B |
| Common Stock Issued | $- | $- | $- | $1.05B | $411.10M |
| Common Stock Repurchased | $- | $-8.08M | $-17.94M | $- | $- |
| Dividends Paid | $-321.08M | $-615.39M | $-698.53M | $-643.47M | $-567.97M |
| Other Financing Activities | $-1.26B | $15.31M | $-88.55M | $-36.67M | $-20.64M |
| Net Cash Used Provided by Financing Activities | $-1.48B | $-1.02B | $-1.34B | $2.95B | $1.40B |
| Effect of Forex Changes on Cash | $-5.22M | $11.40M | $-12.89M | $4.66M | $16.44M |
| Net Change in Cash | $79.22M | $14.41M | $-220.34M | $-94.49M | $-911.62M |
| Cash at End of Period | $335.17M | $255.95M | $241.54M | $461.88M | $556.37M |
| Cash at Beginning of Period | $255.95M | $241.54M | $461.88M | $556.37M | $1.47B |
| Operating Cash Flow | $245.48M | $505.79M | $739.01M | $811.66M | $617.64M |
| Capital Expenditure | $- | $- | $-1.54B | $-65.55M | $-4.29B |
| Free Cash Flow | $245.48M | $505.79M | $-801.35M | $746.11M | $-3.67B |
Cash Flow Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $-412.32M | $-799.05M | $-321.29M | $-875.62M | $-664.29M | $116.89M | $-42.43M | $33.03M | $-140.21M | $222.02M | $190.06M | $631.95M | $206.84M | $171.40M | $114.82M | $163.88M | $110.11M | $131.36M | $109.65M | $81.16M |
| Depreciation and Amortization | $66.20M | $209.72M | $102.24M | $75.59M | $77.30M | $80.65M | $367.97M | $87.59M | $84.86M | $84.64M | $87.32M | $88.76M | $87.66M | $88.44M | $79.07M | $78.61M | $75.15M | $72.59M | $64.38M | $63.83M |
| Deferred Income Tax | $523.00K | $8.00K | $4.89M | $-307.00K | $-2.80M | $-18.58M | $-157.23M | $-7.30M | $11.52M | $- | $- | $- | $- | $-9.29M | $44.13M | $-989.00K | $130.00K | $-26.03M | $22.34M | $25.40M |
| Stock Based Compensation | $2.32M | $14.43M | $8.52M | $7.63M | $3.53M | $11.45M | $6.44M | $11.83M | $16.42M | $11.09M | $10.11M | $11.80M | $13.52M | $13.55M | $12.77M | $12.26M | $12.55M | $12.37M | $12.19M | $10.04M |
| Change in Working Capital | $31.72M | $25.68M | $-61.05M | $-11.96M | $-14.32M | $-20.25M | $-72.34M | $-18.10M | $37.30M | $63.77M | $-29.71M | $-41.77M | $23.81M | $12.37M | $-26.09M | $3.03M | $22.77M | $-17.95M | $14.49M | $-2.08M |
| Accounts Receivables | $- | $4.22M | $-5.44M | $5.37M | $-41.34M | $-38.25M | $-61.62M | $-514.00K | $-47.49M | $-24.70M | $-31.79M | $-12.43M | $-4.72M | $5.85M | $-38.40M | $13.40M | $4.05M | $-6.38M | $-1.95M | $2.14M |
| Inventory | $- | $- | $- | $- | $-90.97M | $18.92M | $71.53M | $514.00K | $47.49M | $1.12M | $25.70M | $- | $- | $- | $- | $- | $-301.00K | $- | $- | $- |
| Accounts Payables | $- | $- | $-15.38M | $-18.88M | $1.68M | $19.33M | $-9.91M | $-15.70M | $49.13M | $23.59M | $6.09M | $-21.65M | $54.06M | $6.21M | $14.26M | $5.06M | $-6.95M | $- | $- | $-4.22M |
| Other Working Capital | $31.72M | $21.46M | $-40.23M | $1.55M | $116.31M | $-20.25M | $-72.34M | $-2.41M | $-11.84M | $63.77M | $-29.71M | $-20.12M | $-30.24M | $12.37M | $-26.09M | $-2.03M | $25.97M | $12.12M | $- | $- |
| Other Non Cash Items | $388.24M | $608.41M | $540.67M | $1.05B | $736.00M | $-11.98M | $-25.88M | $28.61M | $171.21M | $-167.62M | $-93.15M | $-511.36M | $-97.67M | $-64.24M | $-48.17M | $-68.06M | $-45.29M | $-19.19M | $-40.90M | $-71.43M |
| Net Cash Provided by Operating Activities | $76.69M | $59.20M | $35.26M | $74.34M | $135.42M | $158.19M | $76.53M | $135.65M | $181.09M | $213.90M | $164.63M | $179.39M | $234.17M | $212.23M | $176.53M | $188.73M | $175.42M | $153.15M | $182.15M | $106.91M |
| Investments in Property Plant and Equipment | $- | $- | $-108.44M | $-87.05M | $-76.23M | $-67.18M | $-244.44M | $-141.51M | $-423.81M | $-79.68M | $-244.47M | $-792.40M | $-65.55M | $-1.33B | $-1.39B | $-1.82B | $-78.76M | $- | $- | $- |
| Acquisitions Net | $- | $- | $-105.62M | $11.66M | $222.76M | $12.43M | $-162.29M | $-72.90M | $-360.72M | $-12.48M | $-220.67M | $-724.79M | $-1.02B | $-1.22B | $-1.28B | $-1.77B | $-718.17M | $-1.24B | $-252.64M | $-1.97B |
| Purchases of Investments | $43.66M | $-109.86M | $-196.20M | $-164.88M | $-63.72M | $-67.18M | $-82.15M | $-68.61M | $-63.09M | $-53.68M | $-23.02M | $-67.61M | $-35.73M | $-109.83M | $-101.63M | $-42.05M | $-27.82M | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $1.51B | $132.67M | $310.16M | $222.59M | $656.83M | $221.98M | $14.29M | $414.29M | $119.93M | $1.72B | $65.55M | $69.84M | $1.18B | $62.84M | $-29.32M | $- | $-42.26M | $71.58M |
| Other Investing Activities | $48.08M | $253.62M | $-181.00M | $-20.58M | $-222.76M | $-162.32M | $223.87M | $78.21M | $371.06M | $55.74M | $23.32M | $1.67B | $413.79M | $69.84M | $1.20B | $27.91M | $654.31M | $668.76M | $9.41M | $7.29M |
| Net Cash Used for Investing Activities | $91.74M | $143.75M | $1.20B | $-119.26M | $170.22M | $-61.66M | $391.82M | $17.18M | $-462.25M | $324.18M | $-344.91M | $879.03M | $-638.48M | $-1.26B | $-181.26M | $-1.78B | $-199.77M | $-566.73M | $-285.49M | $-1.89B |
| Debt Repayment | $1.08B | $-400.84M | $-688.43M | $111.19M | $-312.90M | $107.31M | $-310.58M | $95.92M | $64.06M | $-265.00M | $198.60M | $-1.07B | $695.28M | $688.64M | $33.41M | $1.16B | $437.63M | $225.00M | $- | $915.95M |
| Common Stock Issued | $- | $- | $- | $- | $95.38M | $- | $- | $- | $- | $- | $- | $- | $10.18M | $140.48M | $121.33M | $779.24M | $116.73M | $124.59M | $108.11M | $61.68M |
| Common Stock Repurchased | $- | $-419.00K | $-2.55M | $-283.00K | $-1.99M | $-520.00K | $-16.00K | $-5.55M | $-18.41M | $-658.00K | $-880.00K | $-27.92M | $- | $- | $- | $- | $- | $- | $- | $- |
| Dividends Paid | $-48.17M | $-90.34M | $-89.81M | $-92.76M | $-91.23M | $-173.85M | $-173.72M | $-176.58M | $-174.00M | $-174.02M | $-174.03M | $-176.49M | $-167.23M | $-165.13M | $-163.44M | $-147.67M | $-144.96M | $-143.26M | $-141.67M | $-138.07M |
| Other Financing Activities | $-1.13B | $-56.53M | $-75.27M | $3.65M | $1.41M | $-118.00K | $22.49M | $-2.91M | $329.05M | $-41.29M | $177.40M | $8.80M | $-27.25M | $13.74M | $-17.59M | $-5.58M | $-26.08M | $7.45M | $2.33M | $-4.34M |
| Net Cash Used Provided by Financing Activities | $-99.81M | $-548.13M | $-853.52M | $22.07M | $-402.73M | $-66.66M | $-461.82M | $-89.12M | $201.17M | $-480.97M | $201.09M | $-1.26B | $510.97M | $677.73M | $-26.29M | $1.79B | $383.31M | $213.77M | $-31.23M | $835.22M |
| Effect of Forex Changes on Cash | $-13.19M | $13.77M | $-2.91M | $-2.89M | $7.16M | $-13.95M | $15.26M | $2.93M | $16.85M | $-14.95M | $-10.06M | $-4.72M | $2.91M | $-4.42M | $1.82M | $4.36M | $7.33M | $8.96M | $9.31M | $-9.16M |
| Net Change in Cash | $55.43M | $-326.80M | $382.21M | $-25.68M | $-90.04M | $15.93M | $21.79M | $66.63M | $-63.14M | $42.16M | $10.75M | $-210.12M | $109.57M | $-371.57M | $-29.20M | $196.72M | $366.29M | $-190.85M | $-125.25M | $-961.81M |
| Cash at End of Period | $335.17M | $279.75M | $606.55M | $224.34M | $250.02M | $345.89M | $329.96M | $308.17M | $241.54M | $304.68M | $262.52M | $251.77M | $461.88M | $352.31M | $723.88M | $753.09M | $556.37M | $190.08M | $380.92M | $506.18M |
| Cash at Beginning of Period | $279.75M | $606.55M | $224.34M | $250.02M | $340.06M | $329.96M | $308.17M | $241.54M | $304.68M | $262.52M | $251.77M | $461.88M | $352.31M | $723.88M | $753.09M | $556.37M | $190.08M | $380.92M | $506.18M | $1.47B |
| Operating Cash Flow | $76.69M | $59.20M | $35.26M | $74.34M | $135.42M | $158.19M | $76.53M | $135.65M | $181.09M | $213.90M | $164.63M | $179.39M | $234.17M | $212.23M | $176.53M | $188.73M | $175.42M | $153.15M | $182.15M | $106.91M |
| Capital Expenditure | $- | $- | $-108.44M | $-87.05M | $-76.23M | $-67.18M | $-244.44M | $-141.51M | $-423.81M | $-79.68M | $-244.47M | $-792.40M | $-65.55M | $-1.33B | $-1.39B | $-1.82B | $-78.76M | $- | $- | $- |
| Free Cash Flow | $76.69M | $59.20M | $-73.18M | $-12.70M | $59.19M | $91.01M | $-167.91M | $-5.86M | $-242.71M | $134.22M | $-79.84M | $-613.01M | $168.62M | $-1.11B | $-1.21B | $-1.63B | $96.65M | $153.15M | $182.15M | $106.91M |
Medical Properties Trust Dividends
Explore Medical Properties Trust's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
13.54%
Dividend Payout Ratio
-13.84%
Dividend Paid & Capex Coverage Ratio
0.76x
Medical Properties Trust Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $0.08 | $0.08 | March 10, 2025 | March 10, 2025 | April 10, 2025 | February 13, 2025 |
| $0.08 | $0.08 | December 12, 2024 | December 12, 2024 | January 09, 2025 | November 21, 2024 |
| $0.08 | $0.08 | September 09, 2024 | September 09, 2024 | October 10, 2024 | August 22, 2024 |
| $0.15 | $0.15 | June 10, 2024 | June 10, 2024 | July 09, 2024 | May 30, 2024 |
| $0.15 | $0.15 | April 19, 2024 | April 22, 2024 | May 01, 2024 | April 12, 2024 |
| $0.15 | $0.15 | December 06, 2023 | December 07, 2023 | January 11, 2024 | November 09, 2023 |
| $0.15 | $0.15 | September 13, 2023 | September 14, 2023 | October 12, 2023 | August 21, 2023 |
| $0.29 | $0.29 | June 14, 2023 | June 15, 2023 | July 13, 2023 | April 27, 2023 |
| $0.29 | $0.29 | March 15, 2023 | March 16, 2023 | April 13, 2023 | February 16, 2023 |
| $0.29 | $0.29 | December 07, 2022 | December 08, 2022 | January 12, 2023 | November 10, 2022 |
| $0.29 | $0.29 | September 14, 2022 | September 15, 2022 | October 13, 2022 | August 18, 2022 |
| $0.29 | $0.29 | June 15, 2022 | June 16, 2022 | July 14, 2022 | May 26, 2022 |
| $0.29 | $0.29 | March 16, 2022 | March 17, 2022 | April 14, 2022 | February 17, 2022 |
| $0.28 | $0.28 | December 08, 2021 | December 09, 2021 | January 13, 2022 | November 11, 2021 |
| $0.28 | $0.28 | September 15, 2021 | September 16, 2021 | October 14, 2021 | August 19, 2021 |
| $0.28 | $0.28 | June 16, 2021 | June 17, 2021 | July 08, 2021 | May 26, 2021 |
| $0.28 | $0.28 | March 17, 2021 | March 18, 2021 | April 08, 2021 | February 18, 2021 |
| $0.27 | $0.27 | December 09, 2020 | December 10, 2020 | January 07, 2021 | November 12, 2020 |
| $0.27 | $0.27 | September 09, 2020 | September 10, 2020 | October 08, 2020 | August 13, 2020 |
| $0.27 | $0.27 | June 17, 2020 | June 18, 2020 | July 16, 2020 | May 21, 2020 |
Medical Properties Trust News
Read the latest news about Medical Properties Trust, including recent articles, headlines, and updates.
Medical Properties Trust: Buying Pressure Builds On Turnaround
Medical Properties Trust is not going bankrupt, with strong liquidity, a healthy asset base, and a well-covered dividend yield. MPW's fiscal 2024 Q4 revenue and FFO beat consensus estimates, trading at a low valuation with significant upside potential. The REIT has reduced debt and diversified its operator base, with Circle Health and Priory Group as major revenue contributors.
Medical Properties Trust Is Overbought, Time To Exit (Technical Analysis)
Since my last analysis, several technical trading indicators show that Medical Properties Trust, Inc. stock has become overbought. I consider MPW stock's overbought condition unsustainable and to be followed by sharp corrections, just as what has occurred multiple times in the recent past. In terms of fundamentals, the current valuation has more than priced in the improvements updated in its earnings report for FY Q4 2024.
The State Of REITs: March 2025 Edition
REITs bounced back (+1.77%) in February and now have a positive year-to-date total return (+0.79%) after the first two months of the year. Large cap (+4.58%), small cap (+2.00%) and mid cap REITs (+0.98%) performed well in February while micro caps (-1.55%) continued to badly underperform their larger peers. 64.97% of REIT securities had a positive total in February.
Dividend Cut Alert: 1 BDC And 1 REIT With Likely Lower Dividends In 2025
The current market environment suggests a potential recession, leading investors to favor durable and income-producing assets. BDCs and REITs are likely to be among the key beneficiaries here. However, with REITs and especially BDCs investors have to be careful in order to avoid falling in a value trap.
Medical Properties Trust: Business Model Sustainability Is Highly Questionable
Medical Properties Trust raised cash by selling assets and issuing high-interest bonds, easing short-term liquidity concerns but raising long-term sustainability questions. MPW's recent refinancing increased its average debt cost significantly, leading to higher annual interest expenses and narrowing the spread between rental yield and debt cost. Despite a significant dividend cut, the Company continues to burn cash, raising debt to cover operating shortfalls, which is unsustainable and long term.
Better Beaten-Down Dividend Stock to Buy: Innovative Industrial Properties or Medical Properties Trust?
Real estate investment trusts (REIT) are a favorite target of income-seeking investors, since the law requires them to distribute most of their earnings as dividends to maintain their tax-advantaged status. However, even REITs face issues that put their dividend programs in danger, sometimes leading to decreased payouts.
Medical Properties: Early Signs Of Stabilization, Maintain Buy
Medical Properties Trust has made significant progress in debt reduction and portfolio stabilization, repaying over $1 billion in debt in the last year. The trust's strategic asset sales and dividend cuts have led to healthier dividend coverage, with a payout ratio of only 44% in 4Q24. Despite a shrinking portfolio and declining funds from operations, MPW's normalized FFO remains stable, suggesting potential for re-rating to book value.
Up 50% This Year, Is Medical Properties Trust a Great Buy Right Now?
Since the start of 2022, Medical Properties Trust (MPW -2.51%) has lost a staggering 75% of its value. Concerns about its troubled tenants, poor financials, and multiple dividend cuts have made this a disastrous investment to own over the past few years.
Buy The Dip With Magnificent Return Potential: Medical Properties Trust
Hospitals all over the United States are sick. Medical Properties Trust, Inc. has been hit hard. Landlords are going to see long-term recovery as operators rotate out. We can collect income from oversold securities primed for recovery.
Stock Picks From Seeking Alpha's February 2025 New Analysts
In February, twenty-three new analysts joined Seeking Alpha, offering diverse stock picks and insights, from biotech to automotive and energy sectors. Analysts provided ratings from Strong Sell to Strong Buy, with detailed justifications based on market trends, company fundamentals, and sector-specific challenges. Key investment theses include bearish views on German automotive and LNG sectors, while bullish on biotech, fintech, and energy companies.
Medical Properties Trust: Dollar-Cost Averaging Your Way To Success
Medical Properties Trust has outperformed the market significantly, with a 41.3% increase since January, driven by strategic share purchases during price drops. Despite recent financial volatility and high leverage, Medical Properties Trust remains undervalued, with a potential upside to $7-$8 per share, justifying a ‘strong buy' rating. The company's book value per share has been eroding, but with resolved issues, I expect stabilization and maintain confidence in the stock's future performance.
Medical Properties Trust: I Remain (Very) Bullish After Assessing The Q4 2024 Data
Bullish outlook reaffirmed after a thorough assessment of Medical Properties Trust's Q4 data. Debt refinancing risks are mitigated, with new tenants exceeding performance expectations. Price target for Q4 2026 raised to a conservative $10 per share, reflecting confidence in financial stability and growth potential.
Medical Properties: The Rally Can Continue
Medical Properties' Q4 earnings exceeded expectations, boosting shares; the REIT's asset sales enhanced liquidity and supported the $0.08 per-share dividend. I previously recommended Medical Properties as a strong buy due to its asset divestment program, which aids in reducing long-term debt. Despite a 17% share price increase after earnings, Medical Properties has upside potential based off of its historical book valuation.
This 5.4%-Yielding Dividend Stock Is Finally on the Road to Recovery
The past several years have been extraordinarily challenging for Medical Properties Trust (MPW 5.74%). The hospital-focused real estate investment trust (REIT) has battled tenant-related headwinds, which put pressure on its cash flow and balance sheet.
REITs Rally As Rates Tumble
US equity markets declined for the fourth week in the past five after a frenetic slate of geopolitical headlines and economic data indicated a sluggish start to 2025 for global growth. The Atlanta Fed's updated growth forecast indicated a -1.5% contraction in first-quarter GDP, while PCE data showed the first monthly decline in personal spending in nearly two years. Buoyed by the interest rate retreat, real estate equities were also a notable source of strength this week as REIT earnings season wrapped up with a surprisingly solid slate of results.
This 6.7%-Yielding Dividend Stock Is Now Much Healthier After Completing $5.5 Billion of Transactions
Medical Properties Trust 's (MPW 16.98%) has experienced ailing financial health in recent years. The bankruptcy of two of its top tenants and rising interest rates put a lot of pressure on the real estate investment trust's (REIT) cash flow and balance sheet.
Medical Properties Trust, Inc. (MPW) Q4 2024 Earnings Call Transcript
Medical Properties Trust, Inc. (NYSE:MPW ) Q4 2024 Earnings Conference Call February 27, 2025 11:00 AM ET Company Participants Charles Lambert - Senior Vice President Edward Aldag - Chairman, President and Chief Executive Officer Rosa Hooper - Senior Vice President, Operations and Secretary Kevin Hanna - Senior Vice President, Controller and Chief Accounting Officer Steven Hamner - Executive Vice President and Chief Financial Officer Conference Call Participants Vikram Garewal - KeyBanc Capital Markets Michael Carroll - RBC Capital Markets Georgi Dinkov - Mizuho Mike Mueller - JPMorgan John Klickowski - Wells Fargo Farrell Granath - Bank of America Omotayo Okusanya - Deutsche Bank Operator Good morning everyone, and welcome to the Q4 2024 Medical Properties Trust Earnings Conference Call. All participants will be in a listen-only mode.
Compared to Estimates, Medical Properties (MPW) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for Medical Properties (MPW) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Medical Properties Trust, Inc. Reports Fourth Quarter and Full-Year Results
BIRMINGHAM, Ala.--(BUSINESS WIRE)--Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced financial and operating results for the fourth quarter and full-year ended December 31, 2024, as well as certain events occurring subsequent to quarter end. Net loss of ($0.69) and Normalized Funds from Operations (“NFFO”) of $0.18 for the 2024 fourth quarter and net loss of ($4.02) and NFFO of $0.80 for the full-year 2024, all on a per share basis. Fourth quarter 2024 net loss.
Unveiling Medical Properties (MPW) Q4 Outlook: Wall Street Estimates for Key Metrics
Evaluate the expected performance of Medical Properties (MPW) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
The State Of REITs: February 2025 Edition
After a brutal December (-6.85%), the REIT sector averaged negative total returns again in January (-1.29%). Large cap (+0.30%) and mid cap REITs (+0.09%) averaged small gains in January, whereas small caps (-0.95%) and micro caps (-7.80%) started the year in the red. Only 42.58% of REIT securities had a positive total during the first month of 2025.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for MPW.